Berdon syndrome

Lore & Background

Berdon syndrome, also called megacystis-microcolon-intestinal hypoperistalsis syndrome, is a generally fatal autosomal recessive genetic disorder. It is more prevalent in females (7 females to 3 males) and is characterized by constipation and urinary retention, microcolon, giant bladder (megacystis), intestinal hypoperistalsis, hydronephrosis, and dilated small bowel. The pathological findings consist of an abundance of ganglion cells in both dilated and narrow areas of the intestine. It is a familial disturbance of unknown cause.

Walter Berdon et al. in 1976 first described the condition in five female infants, two of whom were sisters. All had marked dilatation of the bladder and some had hydronephrosis and the external appearance of prune belly. The infants also had microcolon and dilated small intestines. Several genes are known to be implicated in this syndrome: these include ACTG2, LMOD1, MYH11 and MYLK.

Berdon syndrome is generally diagnosed after birth by the signs and symptoms as well as radiological and surgical findings. It can be diagnosed in the uterus by ultrasound, revealing the enlarged bladder and hydronephrosis. Long-term survival with Berdon syndrome usually requires parenteral nutrition and urinary catheterisation or diversion.

Reader's Guide

Berdon syndrome is significant as a rare, generally fatal autosomal recessive genetic disorder that primarily affects females. First described by Walter Berdon et al. in 1976, it presents with a distinctive set of symptoms including megacystis, microcolon, and intestinal hypoperistalsis. The syndrome's genetic basis involves several genes (ACTG2, LMOD1, MYH11, MYLK), though its cause remains unknown. Diagnosis can occur prenatally via ultrasound or after birth through clinical and radiological findings. Treatment is intensive, often requiring parenteral nutrition, urinary catheterisation or diversion, and ileostomies; multivisceral transplant has been successful in some cases. A 2011 study of 227 children reported the oldest survivor at 24 years, highlighting the syndrome's severity and the challenges of long-term management. Its legacy lies in advancing understanding of congenital gastrointestinal and urinary tract disorders.

Did You Know?

• Berdon syndrome is also called megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIH syndrome).
• It is more prevalent in females, with a ratio of 7 females to 3 males.
• The syndrome was first described in 1976 by Walter Berdon et al. in five female infants, two of whom were sisters.

The 1976 Description

In 1976, Walter Berdon and colleagues published the first formal description of what would bear their name. The case series involved five female infants, two of whom were sisters, all presenting with strikingly enlarged bladders. Several of the children also displayed hydronephrosis and what clinicians described as the external appearance of prune belly. Beyond the urinary findings, the infants showed a microcolon alongside dilated small intestines. This constellation of findings—giant bladder, tiny colon, and sluggish intestinal motility—was novel enough to warrant a new diagnostic label. The condition has since been known by several names, including megacystis-microcolon-intestinal hypoperistalsis syndrome, or MMIH syndrome, but the eponymous Berdon syndrome remains the most widely recognized shorthand in clinical and genetic literature. The fact that the original cohort was entirely female and included a sibling pair hinted early on at both a sex-linked skew in prevalence and a hereditary component, themes that later genetic research would confirm.

Genetics & Pathological Architecture

Berdon syndrome is inherited in an autosomal recessive pattern, meaning both copies of the relevant gene must carry a pathogenic variant for the disorder to manifest. The condition shows a clear sex bias, affecting females roughly twice as often as males in a seven-to-three ratio. At the molecular level, four genes have been implicated: ACTG2, LMOD1, MYH11, and MYLK, all of which play roles in smooth muscle contraction and cytoskeletal organization. Despite this genetic identification, the precise mechanism by which these mutations produce the syndrome's multi-organ phenotype remains classified as a familial disturbance of unknown cause. Histologically, the intestine presents a paradox: rather than the absence of nerve cells seen in Hirschsprung disease, Berdon syndrome shows an abundance of ganglion cells in both the dilated and the narrowed segments of bowel. This finding distinguishes it sharply from other causes of intestinal obstruction and underscores that the defect lies in motility rather than innervation.

Clinical Presentation & Diagnostic Pathway

The clinical picture of Berdon syndrome is dominated by two cardinal features: a massively enlarged bladder and a small, underdeveloped colon. Affected infants typically present with persistent constipation and urinary retention, while imaging reveals hydronephrosis and dilated loops of small bowel. Intestinal hypoperistalsis—the near-absence of coordinated peristaltic contractions—ties these findings together as a single motility failure. Diagnosis is most commonly made after birth, relying on the constellation of physical signs, radiological imaging, and findings at surgery. However, the condition can now be identified prenatally. Fetal ultrasound may reveal the characteristic enlarged bladder and associated hydronephrosis before delivery, giving clinicians and families a window to prepare for the complex postnatal management the infant will require. Because the syndrome is autosomal recessive, genetic counseling for at-risk families becomes a critical component of the diagnostic conversation, particularly when a prior affected child has already been identified.

Treatment, Survival & the Long-Term Outlook

Berdon syndrome is, in most cases, a fatal condition, yet a small number of individuals have achieved long-term survival through aggressive, multidisciplinary intervention. The cornerstone of management is parenteral nutrition, bypassing the non-functional gut entirely to sustain life. Urinary management typically requires either chronic catheterisation or surgical diversion to relieve the obstructed, massively dilated bladder. Among those who survive beyond infancy, the majority also require ileostomies to manage the hypoperistaltic bowel. In more extreme cases, a multivisceral transplant encompassing the stomach, pancreas, small bowel, liver, and large intestine has been performed successfully, representing one of the most complex transplant procedures in pediatric surgery. A 2011 study reviewing 227 children diagnosed with the syndrome reported that the oldest survivor at that time was 24 years old—a remarkable testament to both medical ingenuity and the resilience of these patients, even in the face of a disorder that remains, for most, ultimately unsurvivable.